AU2022215576A1 - Systems and methods for risk based insulin delivery conversion - Google Patents

Systems and methods for risk based insulin delivery conversion Download PDF

Info

Publication number
AU2022215576A1
AU2022215576A1 AU2022215576A AU2022215576A AU2022215576A1 AU 2022215576 A1 AU2022215576 A1 AU 2022215576A1 AU 2022215576 A AU2022215576 A AU 2022215576A AU 2022215576 A AU2022215576 A AU 2022215576A AU 2022215576 A1 AU2022215576 A1 AU 2022215576A1
Authority
AU
Australia
Prior art keywords
insulin
risk
data
assessor
insulin delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022215576A
Other languages
English (en)
Inventor
Stephen D. Patek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dexcom Inc
Original Assignee
Dexcom Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dexcom Inc filed Critical Dexcom Inc
Publication of AU2022215576A1 publication Critical patent/AU2022215576A1/en
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic using feedback of body parameters, e.g. blood sugar or pressure
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/04—Architecture, e.g. interconnection topology
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/04—Architecture, e.g. interconnection topology
    • G06N3/045—Combinations of networks
    • G06N3/0455—Auto-encoder networks; Encoder-decoder networks
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
    • H04N19/00—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals
    • H04N19/70—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals characterised by syntax aspects related to video coding, e.g. related to compression standards
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
    • H04N21/00—Selective content distribution, e.g. interactive television or video on demand [VOD]
    • H04N21/40—Client devices specifically adapted for the reception of or interaction with content, e.g. set-top-box [STB]; Operations thereof
    • H04N21/43—Processing of content or additional data, e.g. demultiplexing additional data from a digital video stream; Elementary client operations, e.g. monitoring of home network or synchronising decoder's clock; Client middleware
    • H04N21/435—Processing of additional data, e.g. decrypting of additional data, reconstructing software from modules extracted from the transport stream
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
    • H04N21/00—Selective content distribution, e.g. interactive television or video on demand [VOD]
    • H04N21/40—Client devices specifically adapted for the reception of or interaction with content, e.g. set-top-box [STB]; Operations thereof
    • H04N21/43—Processing of content or additional data, e.g. demultiplexing additional data from a digital video stream; Elementary client operations, e.g. monitoring of home network or synchronising decoder's clock; Client middleware
    • H04N21/44—Processing of video elementary streams, e.g. splicing a video clip retrieved from local storage with an incoming video stream or rendering scenes according to encoded video stream scene graphs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Signal Processing (AREA)
  • Data Mining & Analysis (AREA)
  • Theoretical Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Artificial Intelligence (AREA)
  • Multimedia (AREA)
  • Surgery (AREA)
  • Databases & Information Systems (AREA)
  • General Engineering & Computer Science (AREA)
  • Software Systems (AREA)
  • Mathematical Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Computing Systems (AREA)
  • Evolutionary Computation (AREA)
  • Computational Linguistics (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
AU2022215576A 2021-02-03 2022-02-03 Systems and methods for risk based insulin delivery conversion Pending AU2022215576A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163145224P 2021-02-03 2021-02-03
US63/145,224 2021-02-03
PCT/US2022/015065 WO2022169942A1 (en) 2021-02-03 2022-02-03 Systems and methods for risk based insulin delivery conversion

Publications (1)

Publication Number Publication Date
AU2022215576A1 true AU2022215576A1 (en) 2023-09-07

Family

ID=80446135

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022215576A Pending AU2022215576A1 (en) 2021-02-03 2022-02-03 Systems and methods for risk based insulin delivery conversion

Country Status (7)

Country Link
US (4) US20220246264A1 (cg-RX-API-DMAC7.html)
EP (1) EP4288968A1 (cg-RX-API-DMAC7.html)
JP (1) JP7802802B2 (cg-RX-API-DMAC7.html)
CN (1) CN116762136A (cg-RX-API-DMAC7.html)
AU (1) AU2022215576A1 (cg-RX-API-DMAC7.html)
CA (1) CA3210305A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022169942A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023070245A1 (en) * 2021-10-25 2023-05-04 Medtrum Technologies Inc. Closed-loop artificial pancreas insulin infusion control system
US20230381414A1 (en) * 2022-05-27 2023-11-30 Insulet Corporation Assessment of past insulin delivery outcomes to automatically tune mda systems
EP4336511A1 (en) * 2022-09-01 2024-03-13 Insulet Corporation Method for detecting occlusions in a fluid path using blood glucose readings
US20240249810A1 (en) * 2023-01-19 2024-07-25 Dexcom, Inc. Systems and methods for risk based insulin delivery conversion
CN117542476A (zh) * 2023-10-08 2024-02-09 上海市闵行区中西医结合医院(上海市闵行区结核病防治院) 一种基于自学习的胰岛素注射剂量监管方法及系统
CN117612692B (zh) * 2024-01-19 2024-04-05 太原理工大学 一种基于连续血糖监测的胰岛素泵故障诊断系统及方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4325520A3 (en) * 2009-05-29 2024-05-15 University Of Virginia Patent Foundation System coordinator and modular architecture for open-loop and closed-loop control of diabetes
US10638981B2 (en) 2015-02-16 2020-05-05 University Of Virginia Patent Foundation Method, system and computer readable medium for assessing actionable glycemic risk
WO2016201120A1 (en) 2015-06-09 2016-12-15 University Of Virginia Patent Foundation Insulin monitoring and delivery system and method for cgm based fault detection and mitigation via metabolic state tracking
MA46993A (fr) * 2016-11-29 2019-10-09 Novo Nordisk As Trousse de départ pour titrage de taux de base
JP7181900B2 (ja) * 2017-06-15 2022-12-01 ノボ・ノルデイスク・エー/エス 患者プロファイルに基づくインスリン滴定アルゴリズム
US20200205743A1 (en) * 2018-12-28 2020-07-02 Dexcom, Inc. Evaluation and visualization of glycemic dysfunction

Also Published As

Publication number Publication date
CA3210305A1 (en) 2022-08-11
CN116762136A (zh) 2023-09-15
US20230329633A1 (en) 2023-10-19
JP7802802B2 (ja) 2026-01-20
US20220240848A1 (en) 2022-08-04
JP2024504276A (ja) 2024-01-31
US20220246264A1 (en) 2022-08-04
WO2022169942A1 (en) 2022-08-11
US20220246265A1 (en) 2022-08-04
EP4288968A1 (en) 2023-12-13

Similar Documents

Publication Publication Date Title
US20230329633A1 (en) Systems and Methods for Risk Based Insulin Delivery Conversion
RU2602040C2 (ru) Способ, система и машиночитаемый носитель для адаптационного рекомендательного контроля сахарного диабета
Kovatchev et al. Control to range for diabetes: functionality and modular architecture
EP3902469B1 (en) Evaluation and visualization of glycemic dysfunction
US20200015760A1 (en) Method to determine individualized insulin sensitivity and optimal insulin dose by linear regression, and related systems
CN114901127B (zh) 治疗区域评估器
JP7785832B2 (ja) 被験者のグルコース変化を判定するための方法
US20240058532A1 (en) System and method for titrating basal insulin doses
CA3160818A1 (en) Joint state estimation prediction that evaluates differences in predicted vs. corresponding received data
US20240249810A1 (en) Systems and methods for risk based insulin delivery conversion
US20220199213A1 (en) Bolus advisor with correction boluses based on risk, carb-free bolus recommender, and meal acknowledgement
JP2022514785A (ja) 患者の血糖値を調節する自動システム
JP7785762B2 (ja) リスクに基づく補正ボーラスを有するボーラスアドバイザ、炭水化物を含まないボーラス推奨器、及び食事承認
WO2023212007A1 (en) System and method for titrating basal insulin doses
US20260102563A1 (en) Systems and methods for insulin infusion
WO2026102335A1 (en) Reference blood glucose based algorithmic titration of diabetes medications using continuous glucose monitoring
WO2025064417A1 (en) Method to avoid hypoglycemia by minimizing late post-prandial insulin infusion in aid system
WO2021188929A2 (en) Systems and methods for a data driven framework for actionable feedback in insulin management for type 1 diabetic subjects on artificial pancreas